Financial News Feed

Stronger Sell Today CANF ranks #3811 as SELL CANDIDATE. Weaker Sell
Today CANF ranks #3811 as SELL CANDIDATE.

CANF stock Can-Fite BioPharma Ltd

CANF stock
Can-Fite BioPharma Ltd

We will be comparing the differences between Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Seattle Genetics Inc. (NASDAQ:SGEN) as far as profitability, institutional ownership, analyst recommendatio...

Read more

Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Synthorx Inc. (NASDAQ:THOR) compete with each other in the Biotechnology sector. We will analyze and compare their risk, analyst recommendations, profit...

Read more

As Biotechnology businesses, Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Therapix Biosciences Ltd. (NASDAQ:TRPX), are affected by compare. This especially...

Read more

PolarityTE Inc. (NASDAQ:PTE) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) are two firms in the Biotechnology that compete against each other. Below is a comparison of their analyst recommendations,...

Read more

Analysts expect Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) to report $-0.04 EPS on March, 22.They anticipate $0.02 EPS change or 33.33% from last quarter’s $-0.06 EPS. The stock decreased 0.88% or ...

Read more

Since Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Sol-Gel Technologies Ltd. (NASDAQ:SLGL) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affec...

Read more

Since Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly aff...

Read more

This is a contrast between Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Aquestive Therapeutics Inc. (NASDAQ:AQST) based on their risk, analyst...

Read more

Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and Progenics Pharmaceuticals Inc. (NASDAQ:PGNX), both competing one another are Biotechnology companies. We will contrast their profitability, institutiona...

Read more

As Biotechnology companies, Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) and EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) are our subject to contrast. And more specifically their dividends, institutional...

Read more

Urovant Sciences Ltd. (NASDAQ:UROV) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspe...

Read more

Biofrontera AG (NASDAQ:BFRA) and Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) compete with each other in the Biotechnology sector. We will analyze and contrast their institutional ownership, profitabil...

Read more

When compared to technical analysis, fundamental analysis typically uses a longer-term approach. Chartists may use a time horizon of days, hours, or even minutes. Fundamental analysis may track data g...

Read more

Analysts expect Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) to report $-0.04 EPS on March, 22.They anticipate $0.02 EPS change or 33.33 % from last quarter’s $-0.06 EPS. The stock increased 3.67% or...

Read more

Investors have placed Can-Fite Biopharma Ltd (CANF) shares on watch as the Aroon Down indicator has moved above 70, indicating that there is downward momentum building for the shares. The Aroon indica...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank